John Gribben was awarded the José Carreras Prize – MediaMedic
MediaMedic shared on LinkedIn:
“EHA International Perspective, John Gribben was awarded the José Carreras Prize, Shares Key Factors Advancing Hematology.
At the 29th Annual Congress of the European Hematology Association (EHA), John Gribben, former EHA chairman and head of the Hematological Center at Barts Cancer Institute, Queen Mary University of London, received the José Carreras Prize for his outstanding contributions to immunology research.
‘Oncology Frontier-Hematology Frontier’ interviewed Professor Gribben to discuss his research findings and feelings about the award.
He also highlighted the significance of patient-centered treatment, the importance of global cooperation, and inclusive clinical trials in advancing hematology and providing the best care for patients worldwide.”
Additional information.
Source: MediaMedic/LinkedIn
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023